| 摘要 |
A pharmaceutical composition for treating chronic liver disease is disclosed in the present invention. The pharmaceutical composition consists of astragalosides and glycyrrhizic acid in a weight ratio of 3-6:1. The pharmaceutical composition is applied to treat chronic hepatitis, hepatic fibrosis, hepatic cirrhosis and the like. The pharmaceutical composition can be manufactured into oral solid preparation, such as tablet, granule, capsule and the like. |
